The Pioneer platform: A novel approach for selection of selective anti-cancer cytotoxic activity in bacteria through co-culturing with engineered human cells
暂无分享,去创建一个
[1] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[2] G. Sethi,et al. Bacteria as a treasure house of secondary metabolites with anticancer potential. , 2021, Seminars in cancer biology.
[3] David J Newman,et al. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. , 2020, Journal of natural products.
[4] G. Lippi,et al. Current Cancer Epidemiology , 2019, Journal of epidemiology and global health.
[5] Adam M. Feist,et al. The emergence of adaptive laboratory evolution as an efficient tool for biological discovery and industrial biotechnology. , 2019, Metabolic engineering.
[6] Zakary S. Singer,et al. Rapid screening of engineered microbial therapies in a 3D multicellular model , 2019, Proceedings of the National Academy of Sciences.
[7] A. Mankin,et al. Binding and Action of Amino Acid Analogs of Chloramphenicol upon the Bacterial Ribosome. , 2018, Journal of molecular biology.
[8] Ruth Hershberg,et al. Rapid Genetic Adaptation during the First Four Months of Survival under Resource Exhaustion , 2017, Molecular biology and evolution.
[9] K. Kannan,et al. Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center , 2016, Proceedings of the National Academy of Sciences.
[10] R. Winn,et al. The soft agar colony formation assay. , 2014, Journal of visualized experiments : JoVE.
[11] Z. Brentzel,et al. Identification of Staphylococcus aureus α‐hemolysin as a protein drug that is secreted by anticancer bacteria and rapidly kills cancer cells , 2014, Biotechnology and bioengineering.
[12] R. Lothe,et al. Epigenetic and genetic features of 24 colon cancer cell lines , 2013, Oncogenesis.
[13] Herman van Tilbeurgh,et al. Characterization of colicin M and its orthologs targeting bacterial cell wall peptidoglycan biosynthesis. , 2012, Microbial drug resistance.
[14] Suzie K. Hight,et al. Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. , 2010, Gastroenterology.
[15] C. Beattie,et al. Noncationic peptides obtained from azurin preferentially enter cancer cells. , 2009, Cancer research.
[16] D. Mengin-Lecreulx,et al. Colicin M Exerts Its Bacteriolytic Effect via Enzymatic Degradation of Undecaprenyl Phosphate-linked Peptidoglycan Precursors* , 2006, Journal of Biological Chemistry.
[17] A. Chakrabarty,et al. Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity , 2005, Cellular microbiology.
[18] A. Chakrabarty,et al. Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Majumdar,et al. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] I. Chopra,et al. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. , 2002, The Journal of antimicrobial chemotherapy.
[21] V. Braun,et al. Ton-dependent colicins and microcins: modular design and evolution. , 2002, Biochimie.
[22] K. Igarashi,et al. Secretion of human EGF and IgE in mammalian cells by recombinant DNA techniques; use of a IL-2 leader sequence. , 1988, Cell structure and function.
[23] H. Noller,et al. Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. , 1987, Biochimie.
[24] V. Braun,et al. Colicin M is an inhibitor of murein biosynthesis , 1982, Journal of bacteriology.
[25] D. Dexter,et al. Heterogeneity of cancer cells from a single human colon carcinoma. , 1981, The American journal of medicine.
[26] B. S. Hartley,et al. Primary structure of a chloramphenicol acetyltransferase specified by R plasmids , 1979, Nature.
[27] J. Rahal,et al. Bactericidal and Bacteriostatic Action of Chloramphenicol Against Meningeal Pathogens , 1979, Antimicrobial Agents and Chemotherapy.
[28] V. Braun,et al. A common receptor protein for phage T5 and colicin M in the outer membrane of Escherichia coli B. , 1973, Biochimica et biophysica acta.
[29] János Bérdy,et al. Bioactive microbial metabolites. , 2005, The Journal of antibiotics.
[30] W. V. Shaw. Chloramphenicol acetyltransferase: enzymology and molecular biology. , 1983, CRC critical reviews in biochemistry.